Related Experiment Video
Updated: Feb 11, 2026

Ex Vivo Organotypic Corneal Model of Acute Epithelial Herpes Simplex Virus Type I Infection
Published on: November 3, 2012
Management of herpes simplex virus epithelial keratitis
Mehdi Roozbahani1, Kristin M Hammersmith
1Cornea Service, Wills Eye Hospital, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA.
Purpose Of Review:
To review recent advancements in the management of herpes simplex virus (HSV) epithelial keratitis.
Recent Findings:
Trifluridine eye drop, acyclovir (ACV) ointment, ganciclovir gel, and oral ACV are still the main therapeutic agents. Cryopreserved amniotic membrane has been recently used as an adjuvant treatment. Resistance to ACV has become a concerning issue. The animal models of HSV vaccine are able to reduce HSV keratitis. New antivirals are under development.
Summary:
Current cases of HSV epithelial keratitis are manageable with available medications, but new advancements are required to decrease disease burden in the future. HSV vaccine can be revolutionary.
Related Concept Videos
What are Viruses?
Tonsillitis II: Management
Impression Management Techniques I: Managing Appearances
Epithelial Tissues and Their Functions
Epithelial tissues provide the body's first line of protection from physical,...
Introduction to Virus
Viruses of Archaea

